Rituximab biosimilar evaluated by network meta-analysis
Haematologica
.
2017 Dec;102(12):e497-e498.
doi: 10.3324/haematol.2017.175042.
Epub 2017 Sep 21.
Authors
Marco Chiumente
1
,
Daniele Mengato
2
,
Andrea Messori
3
Affiliations
1
Scientific Direction, Italian Society for Clinical Pharmacy and Therapeutics, Milano, Italy marcochiume@yahoo.it.
2
Scuola di Specializzazione in Farmacia Ospedaliera, Dipartimento di Scienze del Farmaco, University of Padua, Italy.
3
HTA Unit, ESTAR Toscana, Regional Health Service, Firenze, Italy.
PMID:
28935845
PMCID:
PMC5709121
DOI:
10.3324/haematol.2017.175042
No abstract available
Publication types
Letter
Meta-Analysis
MeSH terms
Biosimilar Pharmaceuticals
Humans
Neoplasms / drug therapy
Network Meta-Analysis
Rituximab / economics
Rituximab / therapeutic use*
Treatment Outcome
Substances
Biosimilar Pharmaceuticals
Rituximab